Abstract
The effects of a novel polypeptide, pancreatic spasmolytic polypeptide (PSP) on a colon carcinoma cell line (HCT 116) were examined. PSP stimulated the incorporation of [3H]thymidine into HCT 116 cells as well as cell proliferation in a dose-dependent manner. Maximal increase in [3H]thymidine incorporation of 50-60% occurred at 3-300, μM PSP. The VIP-mediated-increase in cAMP levels was reduced by PSP at > 1 μM concentrations. PSP is highly homologous to the estrogen-induced pS2 protein in MCF-7 breast cancer cells. We find that PSP also enhanced [3H]thymidine incorporation in MCF-7 cells. These findings indicate for the first time that PSP has growth stimulatory properties.
Original language | English (US) |
---|---|
Pages (from-to) | 303-306 |
Number of pages | 4 |
Journal | FEBS Letters |
Volume | 247 |
Issue number | 2 |
DOIs | |
State | Published - Apr 24 1989 |
Externally published | Yes |
Keywords
- Protein, pS2
- Vasoactive intestinal polypeptide
- cyclic AMP level
ASJC Scopus subject areas
- Biophysics
- Structural Biology
- Biochemistry
- Molecular Biology
- Genetics
- Cell Biology